No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia.

The prognostic role of platelet (PLT) counts was evaluated in a cohort of 1,533 HIV-1-infected subjects followed for a median of 21 months. Thrombocytopenia (TCP), defined as a PLT count < or = 100 x 10(9)/L was present at enrollment in 11.2% of cases, with counts < or = 50 x 10(9)/L (severe TCP) in 5.3%. With the subjects with normal PLT counts (PLT >150 x 10(9)/L) as the reference group, the relative risk of developing acquired immunodeficiency syndrome (AIDS) was 0.8 [95% confidence interval (CI) 0.5-1.3, p = 0.4] for subjects with severe TCP, 2.1 (95% CI 1.4-3.1, p = 0.002) for those with PLT counts ranging from 51 to 100 x 10(9)/L (moderate TCP), and 1.6 (95% CI 1.2-2.1, p = 0.0004) for those with borderline PLT values (PLT ranging from 101 to 150 x 10(9)/L). Most of the risk increase associated with moderate TCP and borderline PLT values was explained by a higher prevalence of subjects with an older age and lower CD4+ cell counts. However, at multivariable analysis considering age, sex, risk group, and zidovudine (ZDV) treatment, the risk for subjects with severe TCP remained significantly lower than that for subjects with moderate TCP and borderline values. These results suggest the existence of different types of HIV-1-associated TCP and also suggest that severe TCP (which often arises in the early phases of infection) is not related to disease progression.

[1]  Y. Najean,et al.  The mechanism of thrombocytopenia in patients with HIV infection. , 1994, The Journal of laboratory and clinical medicine.

[2]  D. Gordon,et al.  Common epitope on HIV p24 and human platelets , 1993, The Lancet.

[3]  J. Groopman,et al.  Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells , 1993 .

[4]  J. Goedert,et al.  Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[5]  D. Devine,et al.  Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. , 1992, The New England journal of medicine.

[6]  J. Sixma,et al.  Thrombocytopenia and the neglected megakaryocyte. , 1992, The New England journal of medicine.

[7]  R. Coutinho,et al.  Prevalence of thrombocytopenia in HIV‐infected and non‐HIV infected drug users and homosexual men , 1992, British journal of haematology.

[8]  É. Oksenhendler,et al.  Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. , 1992, Blood.

[9]  G. Zauli,et al.  Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. , 1992, Blood.

[10]  A. Nosari,et al.  HIV-related thrombocytopenia: four different clinical subsets. , 1992, Haematologica.

[11]  C. Da,et al.  The prognostic importance of thrombocytopenia. , 1991 .

[12]  J. Lefrère,et al.  Frequency and prognostic importance of thrombocytopenia in symptom‐free HIV‐infected individuals: a 5‐year prospective study , 1991, AIDS.

[13]  M. Koury.  Thrombocytopenic purpura in HIV‐seronegative users of intravenous cocaine , 1990, American journal of hematology.

[14]  T. Barbui,et al.  Low incidence of bleeding from HIV‐related thrombocytopenia in drug addicts and hemophiliacs: Implications for therapeutic strategies , 1990, European journal of haematology.

[15]  S. Seremetis,et al.  Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. , 1990, Blood.

[16]  R. Cattaneo,et al.  Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals. , 1990, AIDS research and human retroviruses.

[17]  K. Gelmon,et al.  The effect of zidovudine on platelet count in HIV-infected individuals. , 1990, Journal of acquired immune deficiency syndromes.

[18]  A. Lazzarin,et al.  HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. , 1990, AIDS.

[19]  Y. Cao,et al.  Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Brettle,et al.  Effect of zidovudine on platelet count. , 1989, BMJ.

[21]  É. Oksenhendler,et al.  Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. , 1989, Annals of internal medicine.

[22]  L. Ratner.  Human immunodeficiency virus-associated autoimmune thrombocytopenic purpura: a review. , 1989, The American journal of medicine.

[23]  S. Karpatkin,et al.  Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Karpatkin,et al.  The effect of azidothymidine on HIV-related thrombocytopenia. , 1988, The New England journal of medicine.

[25]  W. Siegenthaler,et al.  [HIV-associated thrombocytopenia]. , 1988, Schweizerische medizinische Wochenschrift.

[26]  J. Phair,et al.  Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. , 1987, Annals of internal medicine.

[27]  S. Danner,et al.  Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection , 1987 .

[28]  D. Linch,et al.  Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection , 1987, British journal of haematology.

[29]  S. Karpatkin,et al.  Risk for the acquired immunodeficiency syndrome among thrombocytopenic and nonthrombocytopenic homosexual men seropositive for the human immunodeficiency virus. , 1987, Annals of internal medicine.

[30]  S. Karpatkin,et al.  Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. , 1986, The Journal of clinical investigation.

[31]  R. Grossman,et al.  Thrombocytopenia in homosexual men , 1986, American journal of hematology.

[32]  P. Volberding,et al.  Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. , 1986, Annals of internal medicine.

[33]  S. Karpatkin,et al.  Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[34]  S. Karpatkin,et al.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men. , 1984, The New England journal of medicine.

[35]  T. Quinn,et al.  Acquired immune deficiency syndrome and pancytopenia. , 1983, JAMA.

[36]  S. Silverman,et al.  Thrombocytopenia and intravenous heroin use. , 1978, Annals of internal medicine.